Related Experiment Videos
Ischemic exercise test: failure to detect partial expression of McArdle's disease
Muscle & Nerve
|July 1, 1987
Summary
The forearm ischemic exercise test (FIET) can miss muscle phosphorylase disorders. Measuring ammonia alongside lactate during FIET helps assess glycolytic pathway function and identify new metabolic disorders.
Area of Science:
- Biochemistry
- Clinical Medicine
- Exercise Physiology
Background:
- The forearm ischemic exercise test (FIET) is crucial for diagnosing muscle metabolic disorders.
- Elevated blood lactate post-exercise typically indicates normal glycolytic function.
- A normal lactate response is often assumed to exclude glycolytic pathway abnormalities.
Purpose of the Study:
- To evaluate the efficacy of FIET in detecting muscle phosphorylase deficiencies.
- To investigate the utility of ammonia measurements in conjunction with lactate during FIET.
- To identify potential limitations of FIET in diagnosing partial metabolic disorders.
Main Methods:
- Forearm ischemic exercise test (FIET) protocol.
- Measurement of blood lactate levels before and after ischemic exercise.
- Measurement of blood ammonia levels before and after ischemic exercise.
- Case study of two patients with partial muscle phosphorylase deficiency.
Main Results:
- Two patients with partial muscle phosphorylase deficiency exhibited a normal lactate increase during FIET.
- FIET successfully identified patients with complete absence of myophosphorylase but not partial forms.
- Ammonia level evaluation proved valuable in confirming adequate glycolytic pathway challenge during exercise.
Conclusions:
- FIET may not detect partial muscle phosphorylase disorders despite a normal lactate response.
- Measuring blood ammonia in addition to lactate enhances the diagnostic capability of FIET.
- Failure to elevate ammonia during ischemic exercise may indicate a novel muscle metabolism disorder.